CURRENT APPROACHES TO TREATING HORMONE REFRACTORY PROSTATE CANCER

CURRENT APPROACHES TO TREATING HORMONE REFRACTORY PROSTATE CANCER

Show other versions (1)

<p>Chemotherapy with docetaxel (Taxotere) used alone or in combination with other agents is today the standard of treatment for metastatic hormone refractory prostate cancer (HRPC). Nevertheless, there remain many unsolved problems associated with its use. A search for drugs, their combination...

Full description

Bibliographic Details
Main Author: O. B. Karyakin
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Onkourologiâ
Subjects:
prostate cancer
hormone resistance
chemotherapy
docetaxel
prostate-specific antigen level
median survival
Online Access:http://oncourology.abvpress.ru/index.php/oncur/article/view/120

Internet

http://oncourology.abvpress.ru/index.php/oncur/article/view/120

Similar Items